FDA Issues and its FDA Data Integrity – 2017
September 1 @ 10:00 am - 11:30 am$150
Many of the data integrity issues that plagued the US drug and biologics industry were eliminated by detailed regulations and stricter enforcement, but many of the problems have resurfaced in recent years among the multitude of foreign manufacturers whoare not familiar with US practices.
Areas Covered in the Session:
Important Regulations related to Data Integrity, including laws related to the
effects of bad data
Guidance Documents related to Data Integrity
Requirements for Computerized Instrument Outputs
Definition of Data Integrity Terms
Importance of Audit Trails
Examples of Violations 483s taken from Warning Letters
Who Will Benefit:
Quality Control and Quality Assurance Workers
Regulatory Affairs Personnel
Product Development Workers
Personnel Planning Clinical Studies
Steven S. Kuwahara , Ph.D. is the founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. Steve has over 30 years of experience in supervising quality control laboratories, including an animal testing facility, and in performing GLP and GMP audits of internal and external testing laboratories . Steve has participated in the development of drugs and
biologicals through all phases of clinical research and final product production.
Event Cost & Details:
One Dial-in One Attendee Price: US$150.00
Compliance4All DBA NetZealous,
The Jamaica Plain News calendar is open to all local organizations and businesses.
Not-for-profits post their events for free.
We ask businesses to pay $5 per event, but waive that fee as a benefit for advertisers.
We examine all submissions after they go live. Here's the form to add your event. Please be sure to include contact information so we can reach you in case there's a problem!
Please go ahead and submit your event — if you are a business, we will be in touch about your $5 fee. Or you can go ahead and pay your $5 fee via PayPal.